Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Gen Surg Casessurgical-critical-care

Gen Surg Cases · surgical-critical-care

Blunt polytrauma with pelvic fracture and hypotension — MTP, whole blood, calcium and TXA timing

Fellowship clinical-management station on blunt-hemorrhage massive transfusion: trigger scores, PROPPR ratios with plasma-first sequencing, whole-blood selection in hypotension, CRASH-2 TXA timing, calcium replacement, targeted fibrinogen and early VTE vigilance.

clinical-management2 min readVerification in progress

Target exams

FRACSFRCS(Gen Surg)ABSFRCSC
On this page
Study tools

Target exams

FRACSFRCS(Gen Surg)ABSFRCSC
Prompt
A 37-year-old man arrives 50 minutes after a high-speed motor vehicle crash: systolic pressure 80, heart rate 132, unstable pelvic fracture with binder, positive FAST, open tibial fracture, 2 units of red cells running, ionised calcium 0.95 mmol/L. The candidate must decide MTP activation with scores, choose whole blood versus components at this pressure, sequence plasma, dose TXA inside the window, manage calcium and fibrinogen, limit crystalloid, and set VTE prophylaxis after haemostasis.

Management walkthrough

Activate the MTP now — physiology plus mechanism plus FAST, scored formally. Systolic pressure 80 with tachycardia, unstable pelvis and positive FAST on 2 units meets every clinical trigger layer, and trigger-meeting patients given 1 to 3 units carry no excess harm signal — waiting for laboratories is the error, not activation.[9] Score it while transfusing: TASH most validated, ABC without laboratories, shock index on vitals with fair performance.[6] Resuscitate 1:1:1 plasma-platelets-red cells fast — exsanguination 9.2% vs 14.6% and haemostasis 86% vs 78% with complications equal — sequencing plasma early and delivering blood to the bay without delay.[1][25][8]

Choose whole blood first at systolic pressure 80. He sits squarely in the verified benefit subgroup: no overall adjusted mortality difference across all comers, but SBP below 90 carries aOR 0.72 and below 70 aOR 0.64 for whole blood versus components.[19] Give low-titre O whole blood first where the bank holds it; otherwise reconstituted 1:1:1 — and state the observational limit rather than promising trial proof.[19][1] Either way, limit crystalloid and accept permissive hypotension to haemostasis in this blunt non-brain-injured bleeder: in-hospital death 6.3% vs 16.3% with fewer respiratory, organ-failure and DIC complications.[24]

TXA 1 g with the first blood — 50 minutes is inside the best window. Dose 1 g loading over 10 minutes then 1 g over 8 hours: all-cause 14.5% vs 16.0%, bleeding death 4.9% vs 5.7%.[2] At 50 minutes he is inside the within-1-hour band (RR 0.68) and the pooled within-2-hours optimal criterion — after 3 hours the same drug carries a harm signal (RR 1.44), so the loading dose runs now, not after theatre.[3][4]

Replace calcium by level; ration fibrinogen by level with bleeding. Ionised 0.95 meets verified hypocalcaemia (1.0 or less): plasma-associated hypocalcaemia runs 53% vs 36% with survival tied to severe lows, while arrival means of 1.08 regardless show shock contributes — so give calcium under citrate load and recheck each round.[14][16] Check fibrinogen with the first round and replace documented low-with-bleeding by protocol — never empirically for every activation, because 6-g-equivalent empirical cryoprecipitate changed 28-day death not at all (25.3% vs 26.1%) and five randomised trials total OR 1.03.[10][11]

After haemostasis: pelvis, prophylaxis and disposition. Definitive pelvic control (binder to frame/external fixation per orthopaedics, angioembolisation on contrast blush), tibial washout and fixation once perfused, ICU with surgical and transfusion-medicine input — and VTE prophylaxis from the moment bleeding allows, because 13% of balanced-resuscitation patients develop VTE with pulmonary embolus predominant in the first 72 hours.[21] Re-escalation triggers are written (pressure, lactate, drain output, calcium, fibrinogen, respiratory status), not assumed.

References15ShowHide
  1. [1]Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA, 2015.PMID 25647203
  2. [2]Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet, 2010.PMID 20554319
  3. [3]Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet, 2011.PMID 21439633
  4. [4]Osawa I, Goto T, Roberts I, et al. Tranexamic acid for trauma: optimal timing of administration based on the CRASH-2 and CRASH-3 trials. Br J Surg, 2025.PMID 40277024
  5. [6]Shih AW, Al Khan S, Wang AY, et al. Systematic reviews of scores and predictors to trigger activation of massive transfusion protocols. J Trauma Acute Care Surg, 2019.PMID 31454339
  6. [8]Meneses E, Boneva D, McKenney M, et al. Massive transfusion protocol in adult trauma population. Am J Emerg Med, 2020.PMID 33071074
  7. [9]Gelbard RB, Griffin RL, Reynolds L, et al. Over-transfusion with blood for suspected hemorrhagic shock is not associated with worse clinical outcomes. Transfusion, 2022.PMID 35753037
  8. [10]Davenport R, Curry N, Fox EE, et al. Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury: The CRYOSTAT-2 Randomized Clinical Trial. JAMA, 2023.PMID 37824155
  9. [11]Burt T, Guilliam A, Cole E, et al. Effect of early administration of fibrinogen replacement therapy in traumatic haemorrhage: a systematic review and meta-analysis of randomised controlled trials with narrative synthesis of observational studies. Crit Care, 2025.PMID 39875966
  10. [14]Moore HB, Tessmer MT, Moore EE, et al. Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock. J Trauma Acute Care Surg, 2020.PMID 32317575
  11. [16]Rushton TJ, Tian DH, Baron A, et al. Hypocalcaemia upon arrival (HUA) in trauma patients who did and did not receive prehospital blood products: a systematic review and meta-analysis. Eur J Trauma Emerg Surg, 2024.PMID 38319350
  12. [19]Torres CM, Stolarski AE, Kenzik KM, et al. Identifying trauma patients who benefit from whole blood transfusion: An effect decomposition analysis on patient survival. Transfusion, 2025.PMID 40717387
  13. [21]Myers SP, Brown JB, Leeper CM, et al. Early versus late venous thromboembolism: A secondary analysis of data from the PROPPR trial. Surgery, 2019.PMID 31230842
  14. [24]Indorewala Y, Nasef Y, Jayagopi K, et al. Permissive hypotension in adult trauma: A systematic review of outcomes across clinical settings, injury type, and resuscitation strategies. Am J Emerg Med, 2026.PMID 42030689
  15. [25]Hynes AM, Westein RJ, Turner TJ, et al. Fresh frozen plasma-first approach is independently associated with improved survival in severely injured patients undergoing massive transfusion. J Trauma Acute Care Surg, 2026.PMID 42275580
PreviousBlunt polytrauma with hypotension at 50 minutes — activation, ratios, TXA clock, calcium and after-haemostasis vigilancesurgical-critical-careNextDamage-control laparotomy with rising MOD scores, oliguria and a tense abdomen — trajectory, IAH and SICsurgical-critical-care